This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riberdy, J. M.
Right arrow Articles by Doherty, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riberdy, J. M.
Right arrow Articles by Doherty, P. C.

 Previous Article  |  Next Article 

Journal of Virology, February 1999, p. 1453-1459, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Protection against a Lethal Avian Influenza A Virus in a Mammalian System

Janice M. Riberdy,1 Kirsten J. Flynn,1 Juergen Stech,2 Robert G. Webster,2 John D. Altman,3 and Peter C. Doherty1,*

Department of Immunology1 and Department of Virology,2 St. Jude Children's Hospital, Memphis, Tennessee 38101, and Emory Vaccine Center, Emory University, Atlanta, Georgia 303223

Received 21 September 1998/Accepted 2 November 1998

The question of how best to protect the human population against a potential influenza pandemic has been raised by the recent outbreak caused by an avian H5N1 virus in Hong Kong. The likely strategy would be to vaccinate with a less virulent, laboratory-adapted H5N1 strain isolated previously from birds. Little attention has been given, however, to dissecting the consequences of sequential exposure to serologically related influenza A viruses using contemporary immunology techniques. Such experiments with the H5N1 viruses are limited by the potential risk to humans. An extremely virulent H3N8 avian influenza A virus has been used to infect both immunoglobulin-expressing (Ig+/+) and Ig-/- mice primed previously with a laboratory-adapted H3N2 virus. The cross-reactive antibody response was very protective, while the recall of CD8+ T-cell memory in the Ig-/- mice provided some small measure of resistance to a low-dose H3N8 challenge. The H3N8 virus also replicated in the respiratory tracts of the H3N2-primed Ig+/+ mice, generating secondary CD8+ and CD4+ T-cell responses that may contribute to recovery. The results indicate that the various components of immune memory operate together to provide optimal protection, and they support the idea that related viruses of nonhuman origin can be used as vaccines.

* Corresponding author. Mailing address: Department of Immunology, St. Jude Children's Hospital, 332 N. Lauderdale St., Memphis, TN 38101-2794. Phone: (901) 495-3470. Fax: (901) 495-3107. E-mail: peter.doherty{at}stjude.org.

Journal of Virology, February 1999, p. 1453-1459, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Quan, F.-S., Compans, R. W., Nguyen, H. H., Kang, S.-M. (2008). Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization. J. Virol. 82: 1350-1359 [Abstract] [Full Text]  
  • van Riel, D., Munster, V. J., de Wit, E., Rimmelzwaan, G. F., Fouchier, R. A.M., Osterhaus, A. D.M.E., Kuiken, T. (2007). Human and Avian Influenza Viruses Target Different Cells in the Lower Respiratory Tract of Humans and Other Mammals. Am. J. Pathol. 171: 1215-1223 [Abstract] [Full Text]  
  • Thomas, P. G., Brown, S. A., Yue, W., So, J., Webby, R. J., Doherty, P. C. (2006). An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses. Proc. Natl. Acad. Sci. USA 103: 2764-2769 [Abstract] [Full Text]  
  • La Gruta, N. L., Kedzierska, K., Pang, K., Webby, R., Davenport, M., Chen, W., Turner, S. J., Doherty, P. C. (2006). A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. Proc. Natl. Acad. Sci. USA 103: 994-999 [Abstract] [Full Text]  
  • Schmitz, N., Kurrer, M., Bachmann, M. F., Kopf, M. (2005). Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection. J. Virol. 79: 6441-6448 [Abstract] [Full Text]  
  • Sangster, M. Y., Riberdy, J. M., Gonzalez, M., Topham, D. J., Baumgarth, N., Doherty, P. C. (2003). An Early CD4+ T Cell-dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T-B Interactions. JEM 198: 1011-1021 [Abstract] [Full Text]  
  • Gnjatic, S., Atanackovic, D., Jager, E., Matsuo, M., Selvakumar, A., Altorki, N. K., Maki, R. G., Dupont, B., Ritter, G., Chen, Y.-T., Knuth, A., Old, L. J. (2003). Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses. Proc. Natl. Acad. Sci. USA 100: 8862-8867 [Abstract] [Full Text]  
  • Seo, S. H., Peiris, M., Webster, R. G. (2002). Protective Cross-Reactive Cellular Immunity to Lethal A/Goose/Guangdong/1/96-Like H5N1 Influenza Virus Is Correlated with the Proportion of Pulmonary CD8+ T Cells Expressing Gamma Interferon. J. Virol. 76: 4886-4890 [Abstract] [Full Text]  
  • Heinen, P. P., de Boer-Luijtze, E. A., Bianchi, A. T. J. (2001). Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection. J. Gen. Virol. 82: 2697-2707 [Abstract] [Full Text]  
  • Tumpey, T. M., Renshaw, M., Clements, J. D., Katz, J. M. (2001). Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection. J. Virol. 75: 5141-5150 [Abstract] [Full Text]  
  • Christensen, J. P., Doherty, P. C., Branum, K. C., Riberdy, J. M. (2000). Profound Protection against Respiratory Challenge with a Lethal H7N7 Influenza A Virus by Increasing the Magnitude of CD8+ T-Cell Memory. J. Virol. 74: 11690-11696 [Abstract] [Full Text]  
  • O’Neill, E., Krauss, S. L., Riberdy, J. M., Webster, R. G., Woodland, D. L. (2000). Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice. J. Gen. Virol. 81: 2689-2696 [Abstract] [Full Text]  
  • Riberdy, J. M., Christensen, J. P., Branum, K., Doherty, P. C. (2000). Diminished Primary and Secondary Influenza Virus-Specific CD8+ T-Cell Responses in CD4-Depleted Ig-/- Mice. J. Virol. 74: 9762-9765 [Abstract] [Full Text]  
  • Cauthen, A. N., Swayne, D. E., Schultz-Cherry, S., Perdue, M. L., Suarez, D. L. (2000). Continued Circulation in China of Highly Pathogenic Avian Influenza Viruses Encoding the Hemagglutinin Gene Associated with the 1997 H5N1 Outbreak in Poultry and Humans. J. Virol. 74: 6592-6599 [Abstract] [Full Text]  
  • Mozdzanowska, K., Maiese, K., Gerhard, W. (2000). Th Cell-Deficient Mice Control Influenza Virus Infection More Effectively Than Th- and B Cell-Deficient Mice: Evidence for a Th-Independent Contribution by B Cells to Virus Clearance. J. Immunol. 164: 2635-2643 [Abstract] [Full Text]  
  • Takada, A., Kuboki, N., Okazaki, K., Ninomiya, A., Tanaka, H., Ozaki, H., Itamura, S., Nishimura, H., Enami, M., Tashiro, M., Shortridge, K. F., Kida, H. (1999). Avirulent Avian Influenza Virus as a Vaccine Strain against a Potential Human Pandemic. J. Virol. 73: 8303-8307 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»